Guaifenesin
FDA Label NDC 49349-511

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Remedyrepack Inc. for the product Guaifenesin (NDC 49349-511). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each immediate-release tablet), purpose, uses, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

DRUG: Guaifenesin

GENERIC: Guaifenesin

DOSAGE: TABLET

ADMINSTRATION: ORAL

NDC: 49349-511-02

COLOR: pink

SHAPE: ROUND

SCORE: No score

SIZE: 10 mm

IMPRINT: 44;588

PACKAGING: 30 in 1 BLISTER PACK

ACTIVE INGREDIENT(S):

  • GUAIFENESIN 200mg in 1
  • INACTIVE INGREDIENT(S):

    • FD&C RED NO. 40
    • MAGNESIUM STEARATE
    • STEARIC ACID
    • POVIDONE
    • CELLULOSE, MICROCRYSTALLINE
    • MALTODEXTRIN
    • SILICON DIOXIDE
    • Remedy_label (Remedy Label)

      Remedy_label (Remedy Label)

* Please review the disclaimer below.